Creation of the Tumor Infiltrating Lymphocytes Specialist Role within the New TIL Program at Dana-Farber Cancer Institute

Puntos clave

• This new role optimizes the management of tumor infiltrating lymphocytes, enhancing cancer treatment outcomes.
• Preliminary feedback indicates a 20% improvement in patient engagement with immunotherapy processes.
• Implementation of a specialist role aims to streamline TIL program workflows and patient interactions.
• Such roles may enable more personalized immunotherapy options for diverse cancer types.